Home » Adeona Pharma Receives Positive Results of Part 1 of Alzheimer’s Study
Adeona Pharma Receives Positive Results of Part 1 of Alzheimer’s Study
Adeona Pharmaceuticals Inc. announced positive results of
Part 1 of its CopperProof-2 clinical study of Zinthionein ZC or zinc cysteine in Alzheimer’s
disease and mild cognitive impairment.
RTTNews
RTTNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May